Gene silencing approaches for the treatment of hepatitis C virus infection

Interferon (IFN)-mediated antiviral activity against the hepatititis C (HCV) through microRNAs ( microRNAs ).

Development of lipid nanoparticles mRNA vaccine against viral Influenza infection

Manufacture and immunogenicity of therapeutic RNA Hepatitis C Virus genotype 4 vaccine by bio-informatics

Evaluation of the Potential role of MicroRNA 126 in Hepatitis C infection patients treatment Outcomes

RNA interference of cysteine protease genes for the management of whitefly (Bemisia tabaci) by oral route

MicroRNA expression in chronic Hepatitis C patients treated with combined pegylated interferon alpha and ribavirin therapy

EFFECTS OF SHORT RNA SEQUENCES ANALOGS AGAINST HCV GENOTYPE 4(A) IN REPLICON CELLS

ADVANCEMENTS IN NANOPARTICLE-BASED RNA THERAPEUTICS AND RNA DELIVERY SYSTEMS

Biochemical and Molecular Alterations of Micro RNA 125b and Micro RNA 489-3p as diseases biomarkers in Hepatitis C Virus (HCV)